Malahleha, Mookho; Dilraj, A.; Jean, J.; Morar, N.S.; Dietrich, J.J.; Ross, M.; Mbatsane, E.; Keefer, M.C.; Ahmedm, K.
(Health and Medical Publishing Group, 2022-01)
BACKGROUND. The high HIV prevalence and incidence in South Africa makes it suitable for recruitment of participants for large-scale HIV
preventive vaccine trials. However, fear of vaccine-induced seropositivity (VISP) may ...